MARY CROWLEY CANCER FOUNDATION

EIN: 262581152 501(c)(3)

DALLAS, TX

Total Revenue
$24,146
Total Expenses
N/A
Total Assets
N/A
Net Assets
N/A
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2008
Legal Domicile
TX
Principal Officer
JENNIFER FOX
Phone
2146581959
Tax Period
2025-01-01 to 2025-06-30

MARY CROWLEY CANCER FOUNDATION, founded in 2008, is a micro nonprofit that reported $24K in total revenue in fiscal year 2024. Revenue fell 82% from the prior year — a significant decline worth monitoring.

Mission

FUNDRAISING ENDOWMENT VEHICLE TO SUPPORT THE MARY CROWLEY MEDICAL RESEARCH CENTER AND OTHER ORGANIZATIONS INVOLVED IN MEDICAL RESEARCH.

Program Service Accomplishments

Program 1

SUPPORT FOR MARY CROWLEY MEDICAL RESEARCH CENTER.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $0
Program Service Revenue $0
Investment Income $24,146
Other Revenue $0
TOTAL REVENUE $24,146

Expense Breakdown

Grants Paid $0
Salaries & Benefits $0
Fundraising Expenses $0
Other Expenses $0
TOTAL EXPENSES $0

Year-over-Year Comparison

2024 2023 Change
Revenue $24,146 $137,756 -0.8%
Expenses N/A N/A N/A
Net Income N/A $137,756 N/A
Key Indicators
✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
5
Independent Members
4
Employees
N/A
Volunteers
4

Governance Policies

✓ Conflict of Interest Policy
✗ Whistleblower Policy
✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
✗ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
2
$183,750
Total Directors
5
$183,750
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
JENNIFER FOX CEO 0.50
Officer Director
$0 $8,750 $183,750
ROY LAMKIN BOARD MEMBER, CHAIRMAN 0.50
Officer Director
$0 $0 $0
BRAD BURRIS BOARD MEMBER 0.50
Director
$0 $0 $0
EDWIN FLORES BOARD MEMBER 0.50
Director
$0 $0 $0
RON CARTER BOARD MEMBER 0.50
Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2025 $24,146 No data No data No data
2024 $137,756 No data $2,664,951 No data
2023 $91,870 No data $2,487,452 No data
2022 $1,086,467 $432,400 $2,165,062 $654,067
2021 $70,333 $1,883 $1,852,184 $68,450
2020 $47,953 $1,379 $1,553,778 $46,574
2019 $47,504 $1,260 $1,421,593 $46,244
2018 $34,319 $1,001,407 $1,161,963 $-967,088
Explore More Nonprofits
→Top 100 Nonprofits in Texas →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare MARY CROWLEY CANCER FOUNDATION with other nonprofits in Texas and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.